Evaxion AS (EVAX)
4.45
+0.31
(+7.49%)
USD |
NASDAQ |
Apr 17, 16:00
4.54
+0.09
(+2.02%)
After-Hours: 20:00
Evaxion SG&A Expense (Quarterly) : 1.491M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Novo Nordisk A/S | 2.718B |
| Ascendis Pharma A/S | 158.13M |
| DBV Technologies SA | 12.79M |
| Cellectis SA | 4.798M |
| Akari Therapeutics Plc | 2.138M |